Adrian Kinkaid
Director Ejecutivo en FUSION ANTIBODIES PLC .
Fortuna: 22 058 $ al 30/04/2024
Cargos activos de Adrian Kinkaid
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
FUSION ANTIBODIES PLC | Director/Miembro de la Junta | 15/08/2022 | - |
Director Ejecutivo | 15/08/2022 | - |
Historial de carrera de Adrian Kinkaid
Antiguos cargos conocidos de Adrian Kinkaid.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom. | Director Ejecutivo | 01/06/2015 | 15/08/2022 |
Formación de Adrian Kinkaid.
The University of Southampton | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 4 |
Operativa
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sectorial
Commercial Services | 2 |
Health Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
FUSION ANTIBODIES PLC | Health Services |
Empresas privadas | 1 |
---|---|
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Adrian Kinkaid
- Experiencia